Cameco CorpRaised full-year outlook for realized uranium prices and revenue despite production disruptions.
Among five nuclear stocks driving market enthusiasm, only Cameco and Centrus Energy sell nuclear fuel today, while Oklo, NuScale Power, and Nano Nuclear Energy remain pre-commercial developers with a combined market value of about $12 billion against roughly $12 million in trailing revenue. Cameco, with a market value of about $41 billion, booked about $2.5 billion in trailing-12-month revenue and raised its full-year outlook for realized uranium prices and revenue despite second-quarter production disruptions. Centrus Energy, valued at about $3.6 billion, generated about $474 million in trailing revenue and operates America's first facility licensed to produce high-assay low-enriched uranium, the fuel most advanced reactor designs require. The three developers hold billions in cash and are pursuing regulatory milestones and first commercial deployments, with Oklo reporting a first-half net loss of $81.6 million on $1.2 million in second-quarter revenue, NuScale holding the first NRC-certified small modular reactor design but only $10.7 million in trailing sales, and Nano Nuclear yet to record any revenue. The sell-off has pushed NuScale about 83% below its 52-week high, Oklo about 77% below, and Nano Nuclear about 70% below, while Cameco sits about 29% below its peak.
Cameco CorpRaised full-year outlook for realized uranium prices and revenue despite production disruptions.
Centrus Energy Corp.Operates first licensed HALEU facility, key for advanced reactors, with strong revenue.
Nano Nuclear Energy Inc. Common StockNo revenue, pre-commercial, stock down 70% from high.
Oklo Inc.Pre-commercial with net loss, stock down 77% from high.
Nuscale Power CorpPre-commercial with minimal sales, stock down 83% from high.
NVIDIA Corporation